These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 7375862
1. Demographic, biologic, and other variables affecting monoamine oxidase activity. Robinson DS, Nies A. Schizophr Bull; 1980; 6(2):298-307. PubMed ID: 7375862 [Abstract] [Full Text] [Related]
4. Measurement of platelet monoamine oxidase using three different substrates in patients with alcoholism and schizophrenia. Tsuji M. Folia Psychiatr Neurol Jpn; 1985; 39(4):521-30. PubMed ID: 3833630 [Abstract] [Full Text] [Related]
8. Platelet and fibroblast monoamine oxidase in alcoholism. Giller E, Nocks J, Hall H, Stewart C, Schnitt J, Sherman B. Psychiatry Res; 1984 Aug; 12(4):339-47. PubMed ID: 6594715 [Abstract] [Full Text] [Related]
9. Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia. Baron M, Levitt M, Gruen R, Kane J, Asnis L. Am J Psychiatry; 1984 Jul; 141(7):836-42. PubMed ID: 6731631 [Abstract] [Full Text] [Related]
12. Platelet monoamine oxidase as a function of nongenetic factors. Friedhoff AJ, Miller JC. Schizophr Bull; 1980 Jul; 6(2):314-9. PubMed ID: 6103576 [Abstract] [Full Text] [Related]
13. Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity. Murphy DL, Belmaker R, Carpenter WT, Wyatt RJ. Br J Psychiatry; 1977 Feb; 130():151-8. PubMed ID: 319862 [Abstract] [Full Text] [Related]
14. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans. Becker RE, Giambalvo CT. Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055 [Abstract] [Full Text] [Related]
15. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM. Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [Abstract] [Full Text] [Related]
16. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. Meltzer HY, Duncavage MB, Jackman H, Arora RC, Tricou BJ, Young M. Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035 [Abstract] [Full Text] [Related]
17. Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. Eckert B, Gottfries CG, Von Knorring L, Oreland L, Wiberg A, Winblad B. Prog Neuropsychopharmacol; 1980 Oct; 4(1):57-68. PubMed ID: 7403345 [No Abstract] [Full Text] [Related]
18. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity. Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH, Wyatt RJ. Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337 [Abstract] [Full Text] [Related]
19. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder]. Lin Y. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991 [Abstract] [Full Text] [Related]
20. Human monoamine oxidase. Lack of brain and platelet correlation. Young WF, Laws ER, Sharbrough FW, Weinshilboum RM. Arch Gen Psychiatry; 1986 Jun; 43(6):604-9. PubMed ID: 3085628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]